comparison of glp-1 integrated weight management platforms agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis Comparing GLP-type therapies for weight

Stress Creates a Circadian Appetite Mismatch. Stress disrupts the natural timing of: cortisol GLP-1 SCFAs the conversion of serotonin to melatonin hunger/satiety hormones This results in: low morning appetite late-night cravings afternoon energy dips dysregulated eating patterns Your appetite becomes mis-timed because your microbiome is mis-timed

GLP1 medicines help people eat less, not by willpower, but by changing how their bodies and brains work

A 2025 meta-analysis examining over 142,000 participants found that tirzepatide produced significantly greater weight loss than semaglutide, an average of 4.23% more body weight lost

Puder and Dr